ARCHIVES

Drug Company Cries Foul Over Clams Of Taxotere’s Superiority To Taxol

This article is from The Cancer Letter archive.

Vol. 19 No. 24 | June 11, 1993

Download PDF Visit The Full Archive

Related Articles

Golde To Step Down At MSK; Porter Joins Hogan & Hartson.

January 26, 2001

ASTRO Members Approve Governance, Dues Changes

January 17, 2003

Nominations Open for Bristol-Myers $25,000

September 29, 1978

In Brief: Ozer, Comis Join Allegheny Cancer Centers; Two Cooperative Groups Under Same Roof

March 21, 1997

Celebrex Studies Show Polyp Reduction, Point To Challenges In Biomarker Validation

April 28, 2006

Obesity At Prostate-Cancer Diagnosis Increases Risk

March 30, 2007